======= NMNAT2 ======= == Gene Information == * **Official Symbol**: NMNAT2 * **Official Name**: nicotinamide nucleotide adenylyltransferase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23057|23057]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BZQ4|Q9BZQ4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NMNAT2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NMNAT2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608701|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Catalyzes the formation of NAD(+) from nicotinamide mononucleotide (NMN) and ATP. Can also use the deamidated form; nicotinic acid mononucleotide (NaMN) as substrate but with a lower efficiency. Cannot use triazofurin monophosphate (TrMP) as substrate. Also catalyzes the reverse reaction, i.e. the pyrophosphorolytic cleavage of NAD(+). For the pyrophosphorolytic activity prefers NAD(+), NADH and NaAD as substrates and degrades nicotinic acid adenine dinucleotide phosphate (NHD) less effectively. Fails to cleave phosphorylated dinucleotides NADP(+), NADPH and NaADP(+). {ECO:0000269|PubMed:16118205, ECO:0000269|PubMed:17402747}. |CTP transf 2| |nicotinamide-nucleotide adenylyltransferase activity| |nicotinate-nucleotide adenylyltransferase activity| |NAD biosynthetic process| |pyridine nucleotide biosynthetic process| |nicotinamide nucleotide biosynthetic process| |pyridine nucleotide metabolic process| |nicotinamide nucleotide metabolic process| |pyridine-containing compound biosynthetic process| |pyridine-containing compound metabolic process| |NAD metabolic process| |oxidoreduction coenzyme metabolic process| |late endosome| |coenzyme biosynthetic process| |cytoplasmic vesicle membrane| |trans-Golgi network| |cofactor biosynthetic process| |nucleotide biosynthetic process| |nucleoside phosphate biosynthetic process| |coenzyme metabolic process| |synapse| |axon| |cofactor metabolic process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |organophosphate biosynthetic process| |nucleobase-containing small molecule metabolic process| |Golgi membrane| |organophosphate metabolic process| |Golgi apparatus| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |organonitrogen compound biosynthetic process| |ATP binding| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp389|PF-06409577 20μM R07 exp389]]|1.8| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13374 * **Expression level (log2 read counts)**: 0.78 {{:chemogenomics:nalm6 dist.png?nolink |}}